http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101460504-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44
filingDate 2013-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101460504-B1
titleOfInvention Pharmaceutical composition for preventing or treating brain injuries comprising cell-free cord blood
abstract The present invention provides a pharmaceutical composition for preventing or treating brain injury comprising cell-free cord blood as an active ingredient. The pharmaceutical composition of the present invention is capable of fundamentally blocking the immune rejection reaction and graft-versus-syndromes that may arise from cells such as umbilical cord blood or stem cells isolated therefrom, as well as significantly promoting the proliferation of neural stem cells in damaged brain And exhibits activity of preventing and treating brain damage.
priorityDate 2013-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130006110-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554068
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6035

Total number of triples: 20.